Compare Kenvue Inc. Common Stock (KVUE) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kenvue Inc. Common Stock vs Medpace Holdings Inc — how do they compare? Kenvue Inc. Common Stock trades at $17.64 (market cap $34.06B), while Medpace Holdings Inc trades at $611.57 (market cap $16.82B). The key difference: Kenvue Inc. Common Stock is far larger — about 2× Medpace Holdings Inc's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| KVUE | MEDP | |
|---|---|---|
Market Cap | $34.06B | $16.82B |
Volume | 23,267,228 | 223,093 |
Sector | Consumer Staples | Health |
52-Week High | $19.83 | $630.19 |
52-Week Low | $14.11 | $393.42 |
Enterprise Value | $41.56B | $16.44B |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 14 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Medpace (MEDP) trades at $617.47, up 2.19% with strong quarterly earnings beats and robust profitability metrics. The stock shows neutral technical signals with key resistance at $620, while fundamentals reveal impressive ROE of 162.15% and consistent revenue growth to $2.8B projected for 2026. Recent CEO stock sales and mixed institutional activity create balanced sentiment ahead of Q3 earnings announcement on October 21, 2026.
MEDP presents growth potential with analyst consensus target of $620.44 and strong historical execution, though elevated valuations (P/E 35.41) and insider selling warrant caution. The stock's upside depends on continued earnings delivery amid competitive medical services landscape.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kenvue Inc. Common Stock
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
